ClinicalTrials.Veeva

Menu

Clinical Efficacy of Different Fissure Sealant Materials in the Newly Erupted Non-Carious First Permanent Molars

I

Izmir Katip Celebi University

Status

Completed

Conditions

Fissure Sealant

Treatments

Device: Beautifil Flow
Device: Fuji® II LC CAPSULE
Device: Fuji Triage® CAPSULE
Device: Clinpro™ XT Varnish

Study type

Interventional

Funder types

Other

Identifiers

NCT04854720
2018-TDU-DİŞF-0050

Details and patient eligibility

About

The aim of this study is to compare the clinical retention rates, marginal adaptation, marginal discoloration and secondary caries formation of two different types of resin-modified glass ionomers (Fuji® II LC; Clinpro™ XT Varnish) and giomer-containing fissure sealant materials (Beautifil Flow) with glass ionomer-containing fissure sealant material (Fuji Triage®) used on newly erupted non-carious first permanent molars as a fissure sealant.

The study included 384 teeth belonging to 182 children, aged between 5 to 9 years old, who have two newly erupted mandibular permanent first molars.

Full description

Firstly, patients were randomly allocated to three main groups: Group 1; Fuji II LC/Fuji Triage (Control) (62 patients), Group 2; Clinpro XT Varnish/Fuji Triage (Control) (60 patients), Group 3; Beautifil Flow/Fuji Triage (Control) (60 patients). After clinical applications, all samples were evaluated in terms of retention, marginal adaptation, marginal discoloration and secondary caries formation using modified USPHS criteria in 6th, 12th and 18th months. Also samples were evaluated in terms of remineralization effect using the laser fluorescence method. Evaluations on occlusal and buccal surfaces were performed separately.

Enrollment

182 patients

Sex

All

Ages

5 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children who have two newly erupted non-carious mandibular permanent first molars that fissure sealant is indicated,
  • Newly erupted first permanent molars show scores of 0 (Sound tooth surface)-1(First visual change in enamel) according to ICDAS II,
  • Newly erupted first permanent molars show scores between 0-13 by using DIAGNOdent device,
  • Children who haven't any systemic disease that prevents the application,
  • Cooperative children who allowed the clinical applications.

Exclusion criteria

  • Teeth with proximal and initial caries,
  • Teeth with applied fissure sealant,
  • Teeth with developmental defects such as hypoplasia and restorations,
  • Non-cooperative children who don't allow the clinical applications,
  • Children and parents who denied the participation in the follow-up appointments.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

182 participants in 3 patient groups

Group 1 (Fuji II LC-Fuji Triage)
Experimental group
Description:
In Group 1, newly erupted mandibular permanent first molars were sealed with resin-modified glass ionomers containing fissure sealant material (Fuji® II LC, GC Corporation, Tokyo, Japan) (test 1). The other first molars were sealed with glass ionomers containing fissure sealant material (Fuji Triage®, GC Corporation, Tokyo, Japan) (control).
Treatment:
Device: Fuji Triage® CAPSULE
Device: Fuji® II LC CAPSULE
Group 2 (Clinpro XT Varnish-Fuji Triage)
Experimental group
Description:
In Group 2, newly erupted mandibular permanent first molars were sealed with resin-modified glass ionomers containing fissure sealant material (Clinpro™ XT Varnish, 3M ESPE, St. Pauls, Miniapolis, MN, USA) (test 2). The other first molars were sealed with glass ionomers containing fissure sealant material (Fuji Triage®, GC Corporation, Tokyo, Japan) (control).
Treatment:
Device: Fuji Triage® CAPSULE
Device: Clinpro™ XT Varnish
Group 3 (Beautiful Flow- Fuji Triage)
Experimental group
Description:
In Group 3, newly erupted mandibular permanent first molars were sealed with Giomer containing fissure sealant material (Beautifil Flow, Shofu, Kyoto, Japan) (test 3). The other first molars were sealed with glass ionomers containing fissure sealant material (Fuji Triage®, GC Corporation, Tokyo, Japan) (control).
Treatment:
Device: Fuji Triage® CAPSULE
Device: Beautifil Flow

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems